Overall, in this randomized controlled trial of outpatients with early COVID-19 disease, the utilization of HCQ was not associated with an alteration in symptom severity; undesireable effects were common in the HCQ group compared to the placebo group. Since the beginning of the pandemic there has been intensive research related to HCQ, including more than… Continue reading Ivermectin ISN’T Hydroxychloroquine Why Is The Fda Ignoring A Potential Covid Treatment?
Remdesivir acts by creating premature termination of viral RNA transcription . Its use improved disease outcomes and reduced viral loads in SARS-CoV-1 infected mice . In rhesus macaques therapeutic treatment with remdesivir showed decrease in SARS-CoV-2 loads, pathologic changes and progression of clinical disease . With this same animal model, remdesivir treatment initiated 12 hours… Continue reading Idsa Guidelines On THE PROCEDURE And Management Of Patients With Covid